BIO-key Q2 revenue flat at $1.9M; net loss narrows to $1.4M

BIO KEY INTERNATIONAL INC

Q2 revenue $1.9M flat YoY; first-half revenue up 29% to $5.9M.
Q2 gross margin improved to 69% from 63%; gross profit $1.3M up 8%.
Q2 net loss narrowed to $1.4M from $1.7M; operating expenses down 10%.
Signed $0.3M defense ministry order in early Q3; expanding EMEA partnerships.
Management confident in FY2023 top-line growth and bottom-line improvements.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

BIO KEY INTERNATIONAL INC reported second quarter ended June 30, 2023 results: revenue $1.9M, net income $1.4M.

Period: second quarter ended June 30, 2023
Revenue: $1.9M
Net income: $1.4M
Result: reported results

Exact text from the filing

filing. --- EX-99.1 (EXHIBIT 99.1) --- EX-99.1 2 ex_560801.htm EXHIBIT 99.1 ex_560801.htm Exhibit 99.1 Identity and Access Management Provider BIO-key Reports Q2 Revenue of $1.9M; Hosts Investor Call Tomorrow, August 15 th at 10am ET WALL, NJ – August 14, 2023 - BIO-key ® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and

View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

BIO KEY INTERNATIONAL INC filing history →

Source: SEC EDGAR

accession 0001437749-23-023794

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.